New cancer treatments in ‘dark matter’ of human genome discovered by researchers \
5 min read
\
\

New cancer treatments in ‘dark matter’ of human genome discovered by researchers

09-Oct-2022
Washington [US], October 8 (ANI): A screening method to discover new drug targets for cancer treatment in the so-called 'Dark Matter' of the genome has been developed by researchers.
09-Oct-2022 Science
\
Researchers discover new cancer treatments in ‘dark matter’ of human genome \
5 min read
\
\

Researchers discover new cancer treatments in ‘dark matter’ of human genome

07-Oct-2022
Washington [US], October 7 (ANI): Researchers have developed a screening method to discover new drug targets for cancer treatment in the so-called 'Dark Matter' of the genome. They applied their method to non-small cell lung cancer (NSCLC), the greatest cancer killer for which effective therapies are urgently sought. They could show that inhibiting identified targets could greatly slow down cancer growth, and their method is adaptable to other cancers.
07-Oct-2022 Health
\
Scientists find potential diagnostic and therapeutic target for lung cancer \
2 min read
\
\

Scientists find potential diagnostic and therapeutic target for lung cancer

18-Jan-2022
Beijing [China], January 18 (ANI): Chinese scientists recently reported the key role of histone acetylation-regulated long noncoding RNA termed as lysosome cell death regulator (LCDR) in tumour survival, providing a potential diagnostic and therapeutic target for lung cancer.
18-Jan-2022 Health
\
Scientists find potential diagnostic and therapeutic target for lung cancer \
2 min read
\
\

Scientists find potential diagnostic and therapeutic target for lung cancer

18-Jan-2022
Beijing [China], January 18 (ANI): Chinese scientists recently reported the key role of histone acetylation-regulated long noncoding RNA termed as lysosome cell death regulator (LCDR) in tumour survival, providing a potential diagnostic and therapeutic target for lung cancer.
18-Jan-2022 Health
\
Non-coding RNAs have great therapeutic potential in cancer research says veteran scientist MRS Rao \
2 min read
\
\

Non-coding RNAs have great therapeutic potential in cancer research says veteran scientist MRS Rao

18-Nov-2021
Thiruvananthapuram Nov 18 PTI Long non-coding ribonucleic acids LncRNAs which are understudied in cancer research have great therapeutic potential said prof MRS Rao veteran scientist and former president Jawaharlal Nehru Centre for Advanced Scientific Research JNCASR here on Thursday Answering questions from students after delivering the 26th Foundation Day lecture of the Rajiv Gandhi Centre for Biotechnology RGCB prof Rao a Padma awardee said clinical trials are currently on for several LncRNA molecules that have a significant impact on cancer treatment in the future A non-coding RNA ncRNA is an RNA molecule that is classified into long and short based on their size Prof Rao delivered the lecture on the topic Long non-coding RNAs in cellular differentiation and cancer - A story of LncRNA mRHL Discovery to Function The foundation stone for RGCB was laid on November 18 1995 and the institute is currently celebrating 25 years of existence Prof Chandrabhas Narayana director RGCB who delivered the welcome address distributed awards for teachers and meritorious students Dr K R Mahendran scientist won the Best Teacher Award based on an appraisal by students Pallavi Chinnu Varghese and Meera V shared this years student merit award a RGCB press release said PTI TGB NVG NVG
18-Nov-2021 National
\